Hematology

Projects

Projects per year 1997 2023

• 5 Active
• 25 Finished

Projects per year

Search results

• Active

  FWOSB110: Nanobody-based individualized AXL targeting to reverse immune suppression and overcome therapy resistance in Acute Myeloid Leukemia

  Vandewalle, N. & De Veirman, K.

  1/11/20 → 31/10/22

  Project: Fundamental

• FWOTM1002: Development of innovative NANObody-based therapies to eradicate REsidual disease in Multiple Myeloma (acronym: NANOREMM)

  De Veirman, K.

  1/10/20 → 30/09/23

  Project: Fundamental

• FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.

  Breckpot, K., De Beck, L. & Maes, K.

  1/10/18 → 30/09/22

  Project: Fundamental

• OZR3286: Bilateral cooperation within the framework of a joint doctoral project: Bench Fee for Joint PhD VUB-UGent, Vlummens Philip

  Vanderkerken, K.

  13/02/18 → 31/12/22

  Project: Fundamental

• SRP48: Strategic Research Programme: Cancer Cell Targeting in Myeloma and Melanoma (MyMe)

  Thielemans, K., Vanderkerken, K. & Breckpot, K.

  1/11/17 → 31/10/22

  Project: Fundamental

• Finished

  AIIFUND40: Junior Grant Award Agreement: Unraveling the balance of tolerance and immunogenicity of multiple myeloma cells.

  Maes, K.

  1/01/19 → 31/12/19

  Project: Fundamental

• FWOKN297: Targeting residual, dormant cancer cells in myeloma: a new approach

  De Veirman, K. & Vanderkerken, K.

  1/01/18 → 31/12/18

  Project: Fundamental

• ANI165: Immune checkpoint modulation in multiple myeloma: can iNKT cells be targeted? Afwerkbeurs toegekend aan Mérédis Favreau.

  Vanderkerken, K., Menu, E. & Favreau, M.

  1/09/16 → 31/08/17

  Project: Fundamental

• FWOAL806: Modulation of the tumor micro-environment in Multiple Myeloma, are exosomes involved?

  Menu, E. & Vanderkerken, K.

  1/01/16 → 31/12/19

  Project: Fundamental

• FWOTM771: Exosomal communication in Multiple Myeloma: friend or foe?

  Vanderkerken, K. & Faict, S.

  1/10/15 → 30/09/19

  Project: Fundamental

• OZR2225: Interaction between embryo and natural killer cells in the endometrium: role at implantation disorders

  De Waele, M.

  1/10/11 → 31/12/11

  Project: Fundamental

• FWOKN234: The interest of aldehyde dehydrogenase positive cells in the evolution of multiple myeloma

  Van Valckenborgh, E. & Vanderkerken, K.

  1/01/11 → 31/12/11

  Project: Fundamental

• OZR2103: Tumor-microenvironmental interactions in multiple myeloma: regulation by epigenetic changes and hypoxia

  Vanderkerken, K.

  1/01/11 → 31/12/14

  Project: Fundamental

• ANI71: Epigenetic regulation and multiple myeloma: identification of potential targets.

  De Bruyne, E. & Vanderkerken, K.

  1/01/11 → 31/12/12

  Project: Fundamental

• FWOKN235: Pre-clinical evaluation of NKT-cells in multiple myeloma

  Menu, E. & Vanderkerken, K.

  1/01/11 → 31/12/11

  Project: Fundamental

• ADSI233: Biological aspects and therapeutical use of mesenchymal stem cells in Multiple Myeloma

  Van Riet, I.

  1/10/10 → 31/12/11

  Project: Fundamental

• HERC10: Fluorescence activated cell sorter for immunobiolgical applications.

  Thielemans, K., Vanderkerken, K., Van Valckenborgh, E. & Aerts, J.

  22/07/10 → 21/07/15

  Project: Fundamental

• ADSI234: Research Scholarship rare tumors: identification of heterogenicity in drug sensitivity at (sub)populations with multiple myeloma. (Foundation Emmanuel Van der Schueren)

  Vanderkerken, K., Van Valckenborgh, E. & Vande Broek, I.

  1/05/10 → 30/04/13

  Project: Fundamental

• OZR1920: Identification and characterisation of the cancer stem cell in multiple myeloma.

  Van Valckenborgh, E.

  1/01/10 → 31/12/11

  Project: Fundamental

• OZR1922: Epigenetic regulation and multiple myeloma: identification of potential targets.

  Vanderkerken, K.

  1/01/10 → 31/12/13

  Project: Fundamental

• OZR1921: Tumor-micro environment interactions as therapeutic target in multiple myeloma

  Vanderkerken, K.

  1/01/10 → 31/12/10

  Project: Fundamental

• FWOAL568: Investigation of epigenetic stability and safety of assisted reproduction technologies

  Bonduelle, M., De Vos, M., Van De Velde, H., De Rycke, M., Liebaers, I. & Van De Velde, H.

  1/01/10 → 31/12/13

  Project: Fundamental

• FWOAL535: Chromosomal abnormalities in human preimplantation embryos and embryonic stem cells: causes, mechanisms and consequences for IVF and regenerative medicine

  Sermon, K., Spits, C., Van De Velde, H., Liebaers, I., Jacobs, K. & Staessens, C.

  1/01/10 → 31/12/13

  Project: Fundamental

• OZR1917: The role of IGF-1 in Multiple Myeloma tumor progression: effects on cell cycle and UPR response.

  Menu, E.

  1/01/10 → 31/12/10

  Project: Fundamental

• FWOAL554: Tumor-microenvoronment interactions in multiple myeloma: regulation by epigenetic modifications and hypoxia.

  Vanderkerken, K., Van Riet, I. & Menu, E.

  1/01/10 → 31/12/13

  Project: Fundamental

• HOA18: Treatment of myltiple myeloma in mice by siRNA

  Vanderkerken, K., Caveliers, V., Kronenberger, P., Lahoutte, T., Muyldermans, S., Vande Broek, I. & Devoogdt, N.

  1/01/09 → 31/12/12

  Project: Fundamental

• FWOAL273: Cell sorting for immunologic applications

  Thielemans, K., Van Camp, B., Kooijman, R., Peters, E. & Vanderkerken, K.

  1/01/04 → 31/12/04

  Project: Fundamental

• HOA1: Expansion and differentiation of embryonic and adult stem cells.

  Bouwens, L., Leyns, L., Volders, M., Sermon, K., Stuy, J. & Van Riet, I.

  1/01/03 → 31/12/06

  Project: Fundamental

• FWOAL133: Study of molecular interactions between endothelial cells and multiple myeloma cells and their role in the regulation of tumor growth and migration.

  Van Camp, B., Vanderkerken, K. & Van Riet, I.

  1/01/00 → 31/12/05

  Project: Fundamental

• SF7: Molecular Mechanisms Wich Lead to Stroma-Indenpendente Growth of Myleom Cells.

  Van Camp, B. & Van Riet, I.

  1/01/97 → 31/12/00

  Project: Fundamental